Phibro Animal Health (PAHC) Non-Current Debt (2013 - 2026)
Phibro Animal Health (PAHC) posted quarterly Non-Current Debt of $597.7 million for Q1 2026, down 3.47% year-over-year from $619.2 million in Q1 2025, and down 0.98% quarter-over-quarter from $603.6 million in Q4 2025.
Phibro Animal Health (PAHC) Non-Current Debt (2013 - 2026) Analysis & Trends
Phibro Animal Health's Non-Current Debt history runs 14 years deep, the most recent figure standing at $597.7 million for Q1 2026.
- In Q1 2026, Non-Current Debt fell 3.47% year-over-year to $597.7 million; the TTM figure through Mar 2026 stood at $597.7 million (down 3.47% YoY), while the FY2025 annual figure was $87.0 million, down 50.57% from the prior year.
- Non-Current Debt for Q1 2026 stood at $597.7 million, down from $603.6 million in the prior quarter.
- The five-year high for Non-Current Debt was $619.2 million in Q1 2025, with the low at $87.0 million in Q2 2025.
- The 5-year median for Non-Current Debt is $179.0 million (2024), against an average of $280.2 million.
- The sharpest annual moves came in 2024 and 2025: Non-Current Debt plunged 61.73% in 2024, then jumped 429.48% in 2025.
- Phibro Animal Health's Non-Current Debt stood at $276.8 million in 2022, then climbed by 7.6% to $297.9 million in 2023, then slumped by 61.73% to $114.0 million in 2024, then surged by 429.48% to $603.6 million in 2025, then declined by 0.98% to $597.7 million in 2026.
- Business Quant data shows PAHC's Non-Current Debt at $597.7 million in Q1 2026, $603.6 million in Q4 2025, and $609.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.42 Bn | 43.46 Bn | - | -8.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.71 Bn | 40.06 Bn | 2.15 Bn | 12.09 Bn |
| 3 | Zoetis | 32.56 Bn | 30.88 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.84 Bn | 5.10 Bn | 27.73 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.41 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.92 Bn | 18.03 Bn | 1.46 Bn | 11.61 Bn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.99 Bn | 11.46 Bn | 798.00 Mn | 3.85 Bn |
| 9 | Dr Reddys Laboratories | 10.15 Bn | 9.99 Bn | - | 130.00 Mn |
| 10 | Phibro Animal Health | 1.46 Bn | 1.38 Bn | 125.68 Mn | 597.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 597.69 Mn |
| Dec 31, 2025 | 603.60 Mn |
| Sep 30, 2025 | 609.52 Mn |
| Jun 30, 2025 | 87.00 Mn |
| Mar 31, 2025 | 619.16 Mn |
| Dec 31, 2024 | 114.00 Mn |
| Sep 30, 2024 | 179.00 Mn |
| Jun 30, 2024 | 176.00 Mn |
| Mar 31, 2024 | 165.00 Mn |
| Dec 31, 2023 | 297.85 Mn |
| Sep 30, 2023 | 154.00 Mn |
| Jun 30, 2023 | 141.00 Mn |
| Mar 31, 2023 | 193.00 Mn |
| Dec 31, 2022 | 276.81 Mn |
| Sep 30, 2022 | 280.74 Mn |
| Jun 30, 2022 | 145.00 Mn |
| Mar 31, 2022 | 124.00 Mn |
| Dec 31, 2021 | 280.32 Mn |
| Sep 30, 2021 | 110.00 Mn |
| Jun 30, 2021 | 95.00 Mn |